JOHN L LAMATTINA Insider Trading $LGND LIGAND PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN L LAMATTINA.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN L LAMATTINA. JOHN L LAMATTINA is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Senior Vice President in PFIZER INC ($PFE) and Director in ZAFGEN, INC. ($ZFGN) and Director in Immunome Inc. ($IMNM).

Over the past year JOHN L LAMATTINA has been an insider in 2 companies. The total value of shares held by JOHN L LAMATTINA in these companies amounts to $2,670,981.

JOHN L LAMATTINA Director
Immunome Inc.
Director
Larimar Therapeutics, Inc.
Director
LIGAND PHARMACEUTICALS INC
Senior Vice President
PFIZER INC
$ 2670981 The total value of shares held by JOHN L LAMATTINA
Insider Rank

JOHN L LAMATTINA ranks 8,512 out of 350,000 insiders. Go to Insider Ranking to see more.

JOHN L LAMATTINA in LIGAND PHARMACEUTICALS INC

Trading Symbol: LGND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN L LAMATTINA: Director
Holdings: 24,768 shares
Current Value: $2,670,981
Latest Transaction: Jun 12 2020
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84

Last 4 weeks trend: BUY
Last 3 months trend: BUY

Last 3 Months Overview:
Buy: 12x
Sell: 5x
Shares Bought: 21,298
Shares Sold: 15,517
Share Difference: +5,781
Value Difference: +$2,558,167

Latest Insider Trading Transactions of JOHN L LAMATTINA in LIGAND PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000013
Value of Purchases ($)00000080,750
No. of Sales0000001
Value of Sales ($)00000080,958

Sentiment: All, IMNM, LRMR, LGND, PFE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 12 2020LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA117.582,468290,1872,468
Jun 12 2020LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00831024,76823.9 K to 24.8 K (+3.47 %)
Aug 05 2019LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseM32.302,50080,7504,835
Aug 05 2019LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorPayment of ExerciseF95.5884780,95823,93724.8 K to 23.9 K (-3.42 %)
Aug 05 2019LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorBuyM32.302,50080,75024,78422.3 K to 24.8 K (+11.22 %)
Jun 07 2019LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA113.594,071462,4254,071
Jun 07 2019LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00835022,28421.4 K to 22.3 K (+3.89 %)
Sep 05 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseM12.533,33541,7880
Sep 05 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorSellS254.963,335850,29221,44924.8 K to 21.4 K (-13.46 %)
Sep 05 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorBuyM12.533,33541,78824,78421.4 K to 24.8 K (+15.55 %)
Jun 21 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA76.772,474189,9292,474
Jun 21 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA76.772,474189,9292,474
Jun 21 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00493021,44921 K to 21.4 K (+2.35 %)
Jun 21 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00493021,44921 K to 21.4 K (+2.35 %)
Jun 04 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseM12.534,00050,1203,335
Jun 04 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorSellS194.514,000778,03920,95625 K to 21 K (-16.03 %)
Jun 04 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorBuyM12.534,00050,12024,95621 K to 25 K (+19.09 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseM10.123,33533,7500
Mar 06 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorSellS160.903,335536,60420,95624.3 K to 21 K (-13.73 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorBuyM10.123,33533,75024,29121 K to 24.3 K (+15.91 %)
Nov 17 2017LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseM10.124,00040,4803,335
Nov 17 2017LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorSellS139.794,000559,16020,95625 K to 21 K (-16.03 %)
Nov 17 2017LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorBuyM10.124,00040,48024,95621 K to 25 K (+19.09 %)
May 26 2017LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA113.502,456278,7562,456
May 26 2017LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00666020,95620.3 K to 21 K (+3.28 %)
May 25 2016LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA119.302,329277,8502,329
May 25 2016LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00188020,29020.1 K to 20.3 K (+0.94 %)
May 25 2016LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00622020,10219.5 K to 20.1 K (+3.19 %)
Nov 13 2015LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGiftG0.001,500019,48021 K to 19.5 K (-7.15 %)
Apr 27 2015LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA89.752,754247,1722,754
Apr 27 2015LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00925020,98020.1 K to 21 K (+4.61 %)

Page:   1